Scholarlink

Background <p>Transforming Growth Factor (TGF) and Bone Morphogenetic Protein (BMP) signalling critically influence pancreatic ductal adenocarcinoma (PDAC) progression, with TGF-B paradoxically exerting both tumour-promoting and -suppressive effects. Parallel to this observation, the specific context-dependent, spatial dynamics of these pathways and their interaction with the tumour microenvironment (TME) remain poorly understood.</p> Methods <p>We performed a spatially resolved analysis of PDAC on a multi-region tissue microarray cohort of 117 curatively resected PDAC specimens consisting of tumour centre (TC), tumour front (TF), and stromal(-predominant) tissue cores each. Protein (ID1, pSMAD2) and mRNA (TGF-A, TGF-B1/2, BMP4, GREM1) expression were assessed in each tissue compartment by immunohistochemistry and in situ hybridization, respectively, quantified by digital image analysis, and correlated with clinicopathologic features.</p> Results <p>ID1 was significantly overexpressed in PDAC cells compared to associated stroma (<i>p</i> &lt; 0.01), while pSMAD2 was largely absent in PDAC cells, but preserved among associated stroma compartments, particularly in TF cores (<i>p</i> = 0.04). Higher stromal GREM1 signal correlated with reduced overall tumoural ID1 protein expression (<i>p</i> = 0.02), and TGF-B2<sup>high</sup>/TGF-A<sup>low</sup> stroma was significantly associated with worse survival (<i>p</i> &lt; 0.01). Intratumoural TGF-B2 was inversely correlated with stromal pSMAD2 expression (<i>p</i> = 0.03) and was associated with lymph node involvement (<i>p</i> = 0.02). FOXP3<sup>+</sup> regulatory T-cells were significantly reduced in TGF-B2<sup>high</sup> tumours (<i>p</i> = 0.04), while higher tumoural TGF-B1 exhibited a trend towards increased FOXP3<sup>+</sup> cells (<i>p</i> = 0.08).</p> Conclusions <p>Our spatial analysis reveals intratumoural heterogeneity of TGF/BMP signalling and its significance for PDAC progression. Notably, stromal TGF-B2 emerges as a prognostic biomarker, while TGF-B1 and ID1 are implicated in adverse clinical and pathologic features. These findings highlight the importance of TGF/BMP signalling niches in the TME with implications for PDAC biology and can inform the development of future therapeutic strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies patient subgroups with adverse outcome

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月18日

查看全文
  • Konstantin Bräutigam,
  • Philipp Zens,
  • Stefan Reinhard,
  • Jessica L. Rohrbach,
  • Simon J. Leedham,
  • Anna S. Wenning,
  • Beat Gloor,
  • Viktor H. Koelzer,
  • Martin Wartenberg

摘要

Background

Transforming Growth Factor (TGF) and Bone Morphogenetic Protein (BMP) signalling critically influence pancreatic ductal adenocarcinoma (PDAC) progression, with TGF-B paradoxically exerting both tumour-promoting and -suppressive effects. Parallel to this observation, the specific context-dependent, spatial dynamics of these pathways and their interaction with the tumour microenvironment (TME) remain poorly understood.

Methods

We performed a spatially resolved analysis of PDAC on a multi-region tissue microarray cohort of 117 curatively resected PDAC specimens consisting of tumour centre (TC), tumour front (TF), and stromal(-predominant) tissue cores each. Protein (ID1, pSMAD2) and mRNA (TGF-A, TGF-B1/2, BMP4, GREM1) expression were assessed in each tissue compartment by immunohistochemistry and in situ hybridization, respectively, quantified by digital image analysis, and correlated with clinicopathologic features.

Results

ID1 was significantly overexpressed in PDAC cells compared to associated stroma (p < 0.01), while pSMAD2 was largely absent in PDAC cells, but preserved among associated stroma compartments, particularly in TF cores (p = 0.04). Higher stromal GREM1 signal correlated with reduced overall tumoural ID1 protein expression (p = 0.02), and TGF-B2high/TGF-Alow stroma was significantly associated with worse survival (p < 0.01). Intratumoural TGF-B2 was inversely correlated with stromal pSMAD2 expression (p = 0.03) and was associated with lymph node involvement (p = 0.02). FOXP3+ regulatory T-cells were significantly reduced in TGF-B2high tumours (p = 0.04), while higher tumoural TGF-B1 exhibited a trend towards increased FOXP3+ cells (p = 0.08).

Conclusions

Our spatial analysis reveals intratumoural heterogeneity of TGF/BMP signalling and its significance for PDAC progression. Notably, stromal TGF-B2 emerges as a prognostic biomarker, while TGF-B1 and ID1 are implicated in adverse clinical and pathologic features. These findings highlight the importance of TGF/BMP signalling niches in the TME with implications for PDAC biology and can inform the development of future therapeutic strategies.